Lucira Health, Inc. (LHDX) Misses Q3 EPS by 277c

Go back to Lucira Health, Inc. (LHDX) Misses Q3 EPS by 277c

Lucira Health Inc. (LHDX) PT Lowered to $0.75 at BofA Securities

November 15, 2022 9:23 AM EST

BofA Securities analyst Derik de Bruin lowered the price target on Lucira Health Inc. (NASDAQ: LHDX) to $0.75 (from $3.00) while maintaining a Underperform rating.

... More